Curant Health Will Be Honored at Awards Dinner & Gala at Flourish Atlanta in June Atlanta, GA USA, May 22, 2017 — The Atlanta Chapter of the Association for Corporate Growth® (ACG), a global professional organization with the mission of Driving Middle-Market Growth®, today announced the 2017 Georgia Fast 40, recognizing the top 40 fastest-growing […]
May 20, 2017 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - The 2017 Asembia Specialty Pharmacy Summit, held April 30 to May 3 in Las Vegas, delivered the goods in two of the hottest topics: value-based contracts and the race for health systems to enter the specialty pharmacy space. Here are my […]
April 27, 2017 - Atlanta, GA – For the fifth year in a row, the Atlanta Business Chronicle has named Curant Health as a Pacesetters Award recipient in recognition of being one of Atlanta’s fastest-growing private companies. This year Curant Health placed 17 on the list of leading Atlanta companies. The Atlanta Business Chronicle considers hundreds […]
March 25, 2017 - Curant Health COO, Marc O'Connor, featured in Medical Economics - Despite recent moves to streamline the prior authorization process, physicians still struggle mightily as they jump through payers’ hoops. Eight in 10 respondents to the Medical Economics Payer Scorecard of nearly 1,100 physicians reported that prior authorizations represent a significant challenge. […]
March 13, 2017 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times - Each year, spring heralds the arrival of the annual Asembia (formerly Armada) Specialty Pharmacy Summit. The significant increase in attendance the event has demonstrated year after year is a testament to the growth of the industry, and the quality content served […]
February 20, 2017 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - The transition to value-based care for payers is not about enrolling patients. In four separate meetings this year with major affiliated, yet independent payers, we heard differing needs and priorities: 1. More connectivity with practitioners 2. A reduction of the cost and risk […]
February 13, 2017 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times - In December 2016, QuintilesIMS reported that US spending on prescription medications will reach upwards of $675 billion by 2021. The pricing pressure on manufacturers is expected to grow along with the demand that specialty therapies, in particular, demonstrate positive outcomes in real-world […]
Audits are one more opportunity to demonstrate the program is working well We can only assume that audits were the focus of so much discussion at this year’s 340B Coalition Winter Conference because the changes that come with the installation of new government officials will inevitably lead to a fresh look at the 340B program. […]
Rumblings of imminent healthcare policy changes were not enough to distract attendees at this year’s J.P. Morgan Healthcare Conference 2017 from their focus on several key themes at this year’s event. Below is a list of our key takeaways from what remains one of the most significant annual healthcare business conferences. The drive to value […]
January 23, 2017 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Despite news breaking on the first steps toward the repeal of the Affordable Care Act (ACA) and President-elect Trump’s comments on pharmaceutical manufacturers and pricing, not all was doom and gloom at the J.P. Morgan 35th Annual Healthcare Conference 2017, January 9-12, […]
